Camp4 Therapeutics Corporation
CAMP
$4.42
$0.020.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -33.53M | -18.33M | -40.28M | -15.10M | -12.59M |
| Total Depreciation and Amortization | 515.00K | 520.00K | 372.00K | 416.00K | 430.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.01M | 7.70M | 29.54M | 3.84M | 1.39M |
| Change in Net Operating Assets | -2.68M | -865.00K | 16.67M | -369.00K | 428.00K |
| Cash from Operations | -12.69M | -10.98M | 6.29M | -11.22M | -10.34M |
| Capital Expenditure | -129.00K | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 36.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -129.00K | -- | 0.00 | 36.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -18.00K | -111.00K | 72.00K |
| Issuance of Common Stock | 4.00K | 57.00K | 25.00M | 32.57M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 3.60M | 14.93M | -- |
| Cash from Financing | 4.00K | 57.00K | 28.59M | 47.38M | 72.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.81M | -10.92M | 34.88M | 36.20M | -10.27M |